CV

Chunnam Vani

Active Director Director DIN 09802463
DIN 09802463 First appointment Nov 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Chunnam Vani

Data last updated:

Chunnam Vani is a Director at Invigor Medical Sciences Private Limited (since 2022). The company operates in Healthcare. Invigor Medical Sciences Private Limited reported revenue of ₹52.5 Lakh (FY 2025).

DIN 09802463
Primary Designation Director
Industry Healthcare
First Appointment 24 Nov 2022
Oldest Company Age 5 yrs
Largest company Invigor Medical Sciences Private Limited · ₹52.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Nov 20222021₹52.5 Lakh (FY 2025)Active

Board colleagues of Chunnam Vani

Directorship timeline

Open interactive timeline →
Invigor Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Chunnam Vani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chunnam Vani

Chunnam Vani currently holds 1 directorship: Invigor Medical Sciences Private Limited (Director, since 24 Nov 2022, revenue ₹52.5 Lakh (FY 2025)).

Chunnam Vani was first appointed on 24 Nov 2022 as Director at Invigor Medical Sciences Private Limited.

The current boards of Chunnam Vani's companies include Lilly Gartia (Invigor Medical Sciences Private Limited), Pappala Naveen (Invigor Medical Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available